Total Payments
$5,798
2024 Payments
$387.73
Companies
32
Transactions
305
Medicare Patients
204
Medicare Billing
$24,350
Payment Breakdown by Category
Food & Beverage$5,798 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,798 | 305 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,052 | 69 | $0 (2024) |
| Janssen Biotech, Inc. | $522.64 | 53 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $374.88 | 14 | $0 (2019) |
| PFIZER INC. | $314.66 | 29 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $311.53 | 23 | $0 (2020) |
| Allergan Inc. | $295.03 | 19 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $283.15 | 3 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $237.76 | 2 | $0 (2020) |
| Synergy Pharmaceuticals Inc | $224.42 | 13 | $0 (2018) |
| UCB, Inc. | $188.14 | 10 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $387.73 | 3 | Alexion Pharmaceuticals, Inc. ($147.87) |
| 2023 | $125.00 | 1 | Novo Nordisk Inc ($125.00) |
| 2022 | $605.10 | 6 | Bayer HealthCare Pharmaceuticals Inc. ($198.26) |
| 2021 | $84.89 | 1 | Bayer HealthCare Pharmaceuticals Inc. ($84.89) |
| 2020 | $342.06 | 15 | Janssen Scientific Affairs, LLC ($125.00) |
| 2019 | $1,496 | 89 | PFIZER INC. ($191.43) |
| 2018 | $1,252 | 97 | AbbVie, Inc. ($300.36) |
| 2017 | $1,505 | 93 | AbbVie, Inc. ($263.05) |
All Payment Transactions
305 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $123.97 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 06/12/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $147.87 | General |
| Category: Rare Disease | ||||||
| 03/13/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $115.89 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Obesity | ||||||
| 12/14/2022 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $125.17 | General |
| Category: Respiratory | ||||||
| 12/01/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $50.15 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $106.52 | General |
| Category: NEUROSCIENCE | ||||||
| 07/13/2022 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 04/13/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $104.41 | General |
| Category: Cardio-renal | ||||||
| 04/13/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $93.85 | General |
| Category: Cardio-renal | ||||||
| 12/09/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $84.89 | General |
| Category: Cardio-renal | ||||||
| 09/09/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/16/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: IMMUNOLOGY | ||||||
| 07/13/2020 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Immunology | ||||||
| 03/11/2020 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Immunology | ||||||
| 03/11/2020 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: Genetic Disease | ||||||
| 02/26/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/12/2020 | Janssen Scientific Affairs, LLC | STELARA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 02/11/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: IMMUNOLOGY | ||||||
| 02/10/2020 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Immunology | ||||||
| 02/10/2020 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 01/28/2020 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/24/2020 | PFIZER INC. | XELJANZ (Drug), INFLECTRA | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 01/20/2020 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/19/2020 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 8 | 204 | 208 | $91,039 | $24,350 |
Total Patients
204
Total Services
208
Medicare Billing
$24,350
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 25 | 25 | $26,125 | $5,627 | 21.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 23 | 23 | $6,210 | $3,611 | 58.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2020 | 18 | 18 | $11,394 | $3,597 | 31.6% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 31 | 31 | $17,490 | $3,341 | 19.1% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 33 | 34 | $20,570 | $3,217 | 15.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 18 | 19 | $4,160 | $2,165 | 52.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 11 | 12 | $3,480 | $2,071 | 59.5% |
| 82274 | Stool analysis for blood | Office | 2020 | 45 | 46 | $1,610 | $720.80 | 44.8% |
About Dr. Robert Levitt, M.D
Dr. Robert Levitt, M.D is a Gastroenterology healthcare provider based in Bryn Mawr, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225054398.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Levitt, M.D has received a total of $5,798 in payments from pharmaceutical and medical device companies, with $387.73 received in 2024. These payments were reported across 305 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($5,798).
As a Medicare-enrolled provider, Levitt has provided services to 204 Medicare beneficiaries, totaling 208 services with total Medicare billing of $24,350. Data is available for 1 year (2020–2020), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Bryn Mawr, PA
- Active Since 07/14/2006
- Last Updated 04/05/2017
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1225054398
Products in Payments
- STELARA (Biological) $760.40
- Humira (Biological) $588.20
- Entyvio (Biological) $328.12
- Kerendia (Drug) $283.15
- UBRELVY (Drug) $272.56
- VIBERZI (Drug) $227.60
- Trulance (Drug) $224.42
- XELJANZ (Drug) $223.82
- DIFICID (Drug) $214.86
- Cimzia (Drug) $188.14
- STRENSIQ (Biological) $147.87
- LINZESS (Drug) $142.00
- Arikayce (Drug) $125.17
- SAPHNELO (Biological) $125.00
- Wegovy (Drug) $125.00
- Xhance (Drug) $123.97
- GATTEX (Drug) $121.01
- XIFAXAN (Drug) $115.16
- KEYTRUDA (Biological) $114.99
- EVENITY (Biological) $105.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Bryn Mawr
Dr. Jeffrey Retig, M.d, M.D
Gastroenterology — Payments: $33,093
Gastroenterology $33,093
Dr. Thomas Mckenna, M.d, M.D
Gastroenterology — Payments: $18,197
Gastroenterology $18,197
Toan Nguyen, M.d, M.D
Gastroenterology — Payments: $11,530
Gastroenterology $11,530
Robert Atkins, M.d, M.D
Gastroenterology — Payments: $9,671
Gastroenterology $9,671
Dr. Nikhita Dharbhamulla, M.d, M.D
Gastroenterology — Payments: $4,634
Gastroenterology $4,634
Jack Collazzo, M.d, M.D
Gastroenterology — Payments: $4,267
Gastroenterology $4,267